Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of $2.64 billion and rated "GREAT" for financial health according to InvestingPro, ...

At Stage 5 of the Global Deterioration Scale, a person can’t safely live without assistance. Unfortunately, the treatments at ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

There remains controversy in the scientific community about the benefit of statins in women, because women have been less studied than men.

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...

Novel treatment development company Algorae Pharmaceuticals (ASX: 1AI) says it is well placed to advance its innovative ...

In a report released today, David Amsellem from Piper Sandler maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report), with ...